Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · IEX Real-Time Price · USD
1.210
+0.010 (0.83%)
At close: Jul 19, 2024, 4:00 PM
1.300
+0.090 (7.44%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Cyclo Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 1996
Revenue
1.131.081.381.590.91.01
Upgrade
Revenue Growth (YoY)
-15.51%-21.76%-13.24%75.54%-10.31%-0.42%
Upgrade
Cost of Revenue
0.090.080.140.160.070.08
Upgrade
Gross Profit
1.040.991.241.430.840.93
Upgrade
Selling, General & Admin
5.464.95.415.053.152.88
Upgrade
Research & Development
13.6314.1899.156.14.87
Upgrade
Other Operating Expenses
2.121.962.451.510.550.73
Upgrade
Operating Expenses
21.221.0416.8615.729.88.48
Upgrade
Operating Income
-20.16-20.05-15.62-14.29-8.96-7.54
Upgrade
Other Expense / Income
-0.770.01-0.17-0-0.02-0.01
Upgrade
Pretax Income
-19.39-20.06-15.45-14.29-8.94-7.53
Upgrade
Net Income
-19.39-20.06-15.45-14.29-8.94-7.53
Upgrade
Shares Outstanding (Basic)
29168621
Upgrade
Shares Outstanding (Diluted)
29168621
Upgrade
Shares Change
159.78%93.50%32.48%298.32%47.81%32.33%
Upgrade
EPS (Basic)
-1.00-1.23-1.83-2.24-5.60-6.97
Upgrade
EPS (Diluted)
-1.00-1.23-1.83-2.24-5.60-6.97
Upgrade
Free Cash Flow
-18-16.19-15.13-15.03-8.59-6.59
Upgrade
Free Cash Flow Per Share
-0.63-0.99-1.79-2.36-5.37-6.09
Upgrade
Gross Margin
92.37%92.16%89.90%90.16%92.65%92.50%
Upgrade
Operating Margin
-1790.06%-1862.69%-1135.51%-901.15%-991.99%-749.06%
Upgrade
Profit Margin
-1721.64%-1863.36%-1123.08%-900.94%-989.80%-747.87%
Upgrade
Free Cash Flow Margin
-1597.89%-1503.84%-1099.71%-947.67%-951.24%-654.37%
Upgrade
EBITDA
-19.38-20.04-15.43-14.27-8.93-7.53
Upgrade
EBITDA Margin
-1720.16%-1861.57%-1121.66%-899.88%-988.39%-747.31%
Upgrade
Depreciation & Amortization
0.020.020.020.020.010.01
Upgrade
EBIT
-19.39-20.06-15.45-14.29-8.94-7.53
Upgrade
EBIT Margin
-1721.64%-1863.36%-1123.08%-900.94%-989.80%-747.87%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).